Salix Pharmaceuticals

Pharmaceutical giant faces a growing list of questions from investors and regulators

Chief executive back at the helm after two-month absence through illness but Robert Ingram retains chairman’s post

Pharma companies’ method of buying drug makers and racking up costs is a threat to R&D

Deal comes days after final US approval for controversial drug

Fast-growing company loses CFO Howard Schiller as it looks to address issues with $11bn Salix Pharma acquisition

European stock markets continue to enjoy lift from ECB’s quantitative easing

Pharma group accepts higher bid as Dublin based bidder Endo withdraws

Company to pay $261.25 per share in cash and stock

US pharma company scraps deal with Italian firm Cosmo Pharmaceuticals

US pharmaceutical company had hoped to gain Irish tax base

Botox maker’s board faces credibility problem, says ISS

Actavis must be getting dizzy from all the approaches

US pharmaceuticals group will merge with Dublin-based Cosmo Technologies to reduce its tax bill